Kyowa Kirin International
Scotland, United Kingdom · Biotechnology, Health Care, Pharmaceutical
Kyowa Kirin International (KKI) is driven by a deep commitment to life, dedicated to addressing the unmet medical needs of patients, their families, and the healthcare professionals who support them. With a team of over 700 people, KKI is a rapidly growing specialty biopharmaceutical company focused on developing and commercializing innovative medicines in oncology, nephrology, and central nervous
Key facts
- Headquarters
- Scotland, United Kingdom
- Employees
- 910
- Industries
- Biotechnology, Health Care, Pharmaceutical
- Website
- kyowakirininternational.com
- Company page
Recent activity at Kyowa Kirin International
Leadership
- Julie Dehaene-Puype, President
Verified email and direct lines for Kyowa Kirin International’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Kyowa Kirin International files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Kyowa Kirin International in the news
- Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO - Business Wire (Sep 29, 2026)
- Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo - Business Wire (Oct 12, 2026)
- (burosumab) for Infants with X-linked Hypophosphataemia in the European Union - Business Wire (Jul 21, 2026)
Companies similar to Kyowa Kirin International
- Jagsonpal Pharmaceuticals · Biotechnology, Health Care, Pharmaceutical, pharmaceuticals
- Hanmi Pharmaceutical Ltd · Biotechnology, Health Care, Pharmaceutical, pharmaceuticals
- Esperion Therapeutics · Biotechnology, Health Care, Pharmaceutical, pharmaceuticals
- Santhera Pharmaceuticals · Biotechnology, Health Care, Pharmaceutical, pharmaceuticals
- Lupin · Biotechnology, Health Care, Pharmaceutical, pharmaceuticals
About Kyowa Kirin International: questions and answers
What does Kyowa Kirin International do?
Kyowa Kirin International (KKI) is driven by a deep commitment to life, dedicated to addressing the unmet medical needs of patients, their families, and the healthcare professionals who support them. With a team of over 700 people, KKI is a rapidly growing specialty biopharmaceutical company focused on developing and commercializing innovative medicines in oncology, nephrology, and central nervous
Where is Kyowa Kirin International headquartered?
Kyowa Kirin International is headquartered in Scotland, United Kingdom.
How many employees does Kyowa Kirin International have?
Kyowa Kirin International has about 910 employees.
Who leads Kyowa Kirin International?
Julie Dehaene-Puype is a President at Kyowa Kirin International.
What is the latest news on Kyowa Kirin International?
On Nov 03, 2025, Kyowa Kirin International Appoints Julie Dehaene-Puype as President
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy